Therapy and epidemiology of autism-clostridial spores as key elements

被引:73
作者
Finegold, Sydney M. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90073 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90073 USA
关键词
D O I
10.1016/j.mehy.2007.07.019
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This manuscript reviews evidence indicating that intestinal, bacteria, specifically clostridia, may play a role in certain cases of autism and hypothesizes that the clostridial spores (which are notably resistant to antimicrobial agents and commonly used germicides) are involved in: (1) relapse in the autistic subject after a response to an agent such as oral vancomycin, after the drug is discontinued, (2) the unexplained increased incidence of autism in recent years, and (3) the unexplained increase in numbers of multiple cases in the same family. Hypothesis (1), if established as valid, would spur research to find well-tolerated and safe agents that could be given together with vancomycin (or other appropriate antimicrobial agent) to eliminate spores; this would revolutionize the therapeutic approach. Hypotheses (2) and (3) relate to widespread use of antimicrobial agents, poor hygiene in young autistic children, and difficulty in removing spores from the home environment. These tatter two hypotheses have major implications with regard to the epidemiology of this important and distressing disease and would encourage research into methods to eliminate clostridial spores from the home and other environments. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:508 / 511
页数:4
相关论文
共 13 条
  • [1] BETTIN K, 1994, INFECT CONT HOSP EP, V15, P697
  • [2] Autism and Clostridium tetani
    Bolte, ER
    [J]. MEDICAL HYPOTHESES, 1998, 51 (02) : 133 - 144
  • [3] In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility of pathology involving bowel flora
    Finegold, SM
    St John, S
    Vu, AW
    Li, CM
    Molitoris, D
    Song, YL
    Liu, CX
    Wexler, HM
    [J]. ANAEROBE, 2004, 10 (04) : 205 - 211
  • [4] Gastrointestinal microflora studies in late-onset autism
    Finegold, SM
    Molitoris, D
    Song, YL
    Liu, CX
    Vaisanen, ML
    Bolte, E
    McTeague, M
    Sandler, R
    Wexler, H
    Marlowe, EM
    Collins, MD
    Lawson, PA
    Summanen, P
    Baysallar, M
    Tomzynski, TJ
    Read, E
    Johnson, E
    Rolfe, R
    Nasir, P
    Shah, H
    Haake, DA
    Manning, P
    Kaul, A
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 : S6 - S16
  • [5] Herbert MR, 2005, CLIN NEUROPSYCHIATR, V2, P354
  • [6] Jyonouchi H, 2001, J ALLERGY CLIN IMMUN, V107, pS274
  • [7] Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders
    MacFabe, Derrick F.
    Cain, Donald P.
    Rodriguez-Capote, Karina
    Franklin, Andrew E.
    Hoffman, Jennifer E.
    Boon, Francis
    Taylor, A. Roy
    Kavaliers, Martin
    Ossenkopp, Klaus-Peter
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2007, 176 (01) : 149 - 169
  • [8] EPIDEMIOLOGICAL ASPECTS OF CLOSTRIDIUM-DIFFICILE-INDUCED DIARRHEA AND COLITIS
    MULLIGAN, ME
    GEORGE, WL
    ROLFE, RD
    FINEGOLD, SM
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (11) : 2533 - 2538
  • [9] Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children
    Parracho, HMRT
    Bingham, MO
    Gibson, GR
    McCartney, AL
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (10) : 987 - 991
  • [10] Short-term benefit from oral vancomycin treatment of regressive-onset autism
    Sandler, RH
    Finegold, SM
    Bolte, ER
    Buchanan, CP
    Maxwell, AP
    Väisänen, ML
    Nelson, MN
    Wexler, HM
    [J]. JOURNAL OF CHILD NEUROLOGY, 2000, 15 (07) : 429 - 435